The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis

Renal cell cancer is the most common type of kidney cancer in adults, and clear cell renal cell carcinoma (ccRCC) is the most diagnosed type. T cell immunoglobulin and mucin-domain-containing-3 (TIM-3) belongs to immunological checkpoints that are key regulators of the immune response. One of the kn...

Full description

Bibliographic Details
Main Authors: Anna Andrzejczak, Krzysztof Tupikowski, Anna Tomkiewicz, Bartosz Małkiewicz, Kuba Ptaszkowski, Aleksandra Domin, Tomasz Szydełko, Lidia Karabon
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/3/2042
_version_ 1797624500516290560
author Anna Andrzejczak
Krzysztof Tupikowski
Anna Tomkiewicz
Bartosz Małkiewicz
Kuba Ptaszkowski
Aleksandra Domin
Tomasz Szydełko
Lidia Karabon
author_facet Anna Andrzejczak
Krzysztof Tupikowski
Anna Tomkiewicz
Bartosz Małkiewicz
Kuba Ptaszkowski
Aleksandra Domin
Tomasz Szydełko
Lidia Karabon
author_sort Anna Andrzejczak
collection DOAJ
description Renal cell cancer is the most common type of kidney cancer in adults, and clear cell renal cell carcinoma (ccRCC) is the most diagnosed type. T cell immunoglobulin and mucin-domain-containing-3 (TIM-3) belongs to immunological checkpoints that are key regulators of the immune response. One of the known TIM-3 ligands is galectin-9 (<i>LGALS9</i>). A limited number of studies have shown an association between <i>TIM-3</i> polymorphisms and cancer risk in the Asian population; however, there is no study on the role of <i>LGALS9</i> polymorphisms in cancer. The present study aimed to analyze the influence of <i>TIM-3</i> and <i>LGALS9</i> polymorphisms on susceptibility to ccRCC and patient overall survival (OS), with over ten years of observations. Using TaqMan probes, ARMS–PCR, and RFPL-PCR, we genotyped two <i>TIM-3</i> single-nucleotide polymorphisms (SNPs): rs1036199 and rs10057302, and four <i>LGALS9</i> SNPs: rs361497, rs3751093, rs4239242, and rs4794976. We found that the presence of the rs10057302 A allele (AC + AA genotypes) as well as the rs4794976 T allele (GT + TT genotypes) decreased susceptibility to ccRCC by two-fold compared to corresponding homozygotes. A subgroup analysis showed the association of some SNPs with clinical features. Moreover, <i>TIM-3</i> rs1036199 significantly influenced OS. Our results indicate that variations within <i>TIM-3</i> and <i>LGALS9</i> genes are associated with ccRCC risk and OS.
first_indexed 2024-03-11T09:43:14Z
format Article
id doaj.art-cf4c409d84a0413a9a47db8bc58d9194
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T09:43:14Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-cf4c409d84a0413a9a47db8bc58d91942023-11-16T16:51:30ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-01-01243204210.3390/ijms24032042The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and PrognosisAnna Andrzejczak0Krzysztof Tupikowski1Anna Tomkiewicz2Bartosz Małkiewicz3Kuba Ptaszkowski4Aleksandra Domin5Tomasz Szydełko6Lidia Karabon7Laboratory of Genetics and Epigenetics of Human Diseases, Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, PolandSubdivision of Urology, Lower Silesian Center for Oncology, Pulmonology and Hematology, 53-413 Wrocław, PolandLaboratory of Genetics and Epigenetics of Human Diseases, Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, PolandUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wrocław, PolandDepartment of Clinical Biomechanics and Physiotherapy in Motor System Disorders, Wrocław Medical University, 50-556 Wrocław, PolandLaboratory of Genetics and Epigenetics of Human Diseases, Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, PolandUniversity Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wrocław, PolandLaboratory of Genetics and Epigenetics of Human Diseases, Department of Experimental Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wrocław, PolandRenal cell cancer is the most common type of kidney cancer in adults, and clear cell renal cell carcinoma (ccRCC) is the most diagnosed type. T cell immunoglobulin and mucin-domain-containing-3 (TIM-3) belongs to immunological checkpoints that are key regulators of the immune response. One of the known TIM-3 ligands is galectin-9 (<i>LGALS9</i>). A limited number of studies have shown an association between <i>TIM-3</i> polymorphisms and cancer risk in the Asian population; however, there is no study on the role of <i>LGALS9</i> polymorphisms in cancer. The present study aimed to analyze the influence of <i>TIM-3</i> and <i>LGALS9</i> polymorphisms on susceptibility to ccRCC and patient overall survival (OS), with over ten years of observations. Using TaqMan probes, ARMS–PCR, and RFPL-PCR, we genotyped two <i>TIM-3</i> single-nucleotide polymorphisms (SNPs): rs1036199 and rs10057302, and four <i>LGALS9</i> SNPs: rs361497, rs3751093, rs4239242, and rs4794976. We found that the presence of the rs10057302 A allele (AC + AA genotypes) as well as the rs4794976 T allele (GT + TT genotypes) decreased susceptibility to ccRCC by two-fold compared to corresponding homozygotes. A subgroup analysis showed the association of some SNPs with clinical features. Moreover, <i>TIM-3</i> rs1036199 significantly influenced OS. Our results indicate that variations within <i>TIM-3</i> and <i>LGALS9</i> genes are associated with ccRCC risk and OS.https://www.mdpi.com/1422-0067/24/3/2042TIM-3HAVCR2galectin-9 (<i>LGALS9</i>)clear cell renal cell carcinoma (ccRCC)single-nucleotide gene polymorphism (SNP)immunological checkpoint
spellingShingle Anna Andrzejczak
Krzysztof Tupikowski
Anna Tomkiewicz
Bartosz Małkiewicz
Kuba Ptaszkowski
Aleksandra Domin
Tomasz Szydełko
Lidia Karabon
The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
International Journal of Molecular Sciences
TIM-3
HAVCR2
galectin-9 (<i>LGALS9</i>)
clear cell renal cell carcinoma (ccRCC)
single-nucleotide gene polymorphism (SNP)
immunological checkpoint
title The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
title_full The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
title_fullStr The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
title_full_unstemmed The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
title_short The Variations’ in Genes Encoding TIM-3 and Its Ligand, Galectin-9, Influence on ccRCC Risk and Prognosis
title_sort variations in genes encoding tim 3 and its ligand galectin 9 influence on ccrcc risk and prognosis
topic TIM-3
HAVCR2
galectin-9 (<i>LGALS9</i>)
clear cell renal cell carcinoma (ccRCC)
single-nucleotide gene polymorphism (SNP)
immunological checkpoint
url https://www.mdpi.com/1422-0067/24/3/2042
work_keys_str_mv AT annaandrzejczak thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT krzysztoftupikowski thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT annatomkiewicz thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT bartoszmałkiewicz thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT kubaptaszkowski thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT aleksandradomin thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT tomaszszydełko thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT lidiakarabon thevariationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT annaandrzejczak variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT krzysztoftupikowski variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT annatomkiewicz variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT bartoszmałkiewicz variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT kubaptaszkowski variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT aleksandradomin variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT tomaszszydełko variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis
AT lidiakarabon variationsingenesencodingtim3anditsligandgalectin9influenceonccrccriskandprognosis